HOMCY CHARLES J 4

What Happened
Charles J. Homcy, a director of BridgeBio Pharma (BBIO), had 788 shares of common stock withheld on 2026-06-20 to satisfy his tax obligation related to the vesting of RSUs. The withheld shares were valued at $66.27 each, for a total of about $52,221. This was a tax-withholding action, not an open-market sale or purchase.

Key Details

• Transaction date: 2026-06-20; Filing date: 2026-06-23 (Form 4 accession 0001470831-26-000569).
• Withheld: 788 shares at $66.27 per share; total value ≈ $52,221.
• Footnote: Those 788 shares were withheld to cover taxes on the vesting of 2,196 RSU shares.
• Shares owned after transaction: Not stated in the provided filing.
• Filing timeliness: No late-filing indicator provided in the summarized data.

Context
Share withholding to cover taxes is a routine administrative action when RSUs vest. It is effectively a cashless method of satisfying tax withholding and does not necessarily signal the insider is selling additional shares or changing their investment view. For investors, purchases or outright open-market sales tend to be more informative about insider sentiment than tax-withholding events.